Publications
- Efficacy of anti-VEGF therapy (aflibercept) in advanced colorectal cancer2019 | Publication without faculty affiliation
- Význam biomarkerů pro léčbu anti-VEGF inhibitory a jejíí účinnost u metastatického kolorektálního karcinomu2018 | Publication without faculty affiliation
- Efficacy of anti-VEGF therapy with afliberceptem in advanced colorectal cancer2017 | Publication without faculty affiliation
- Regorafenib monotherapy in pretreated metastatic colorectal cancer (CORRECT): an international, multicenter, randomized, placebo-controlled clinical trial Phase 32013 | Second Faculty of Medicine
- Klinická onkologie2023 | Second Faculty of Medicine, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen
- Options and rationale for reinstituting anti-EGFR therapy in pretreated RAS wild-type advanced colorectal carcinomas2023 | Publication without faculty affiliation
- Nové trendy v léčbě pokročilého kolorektálního karcinomu2023 | Publication without faculty affiliation
- Indications for venous access in oncology - recommendations of national professional societies and current state in the Czech Republic2021 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Nanoliposomal irinotecan in patients with pancreatic cancer - overall survival and results of patients treated according to the protocol in the NAPOLI-1 study2021 | Publication without faculty affiliation
- Possibilities and substantiation of re-treatment with anti-EGFR drugs for pre-treated RAS wild-type advanced colorectal cancers2021 | Publication without faculty affiliation
Loading network view...